Theriva Biologics, Inc. Logo

Theriva Biologics, Inc.

Clinical-stage company developing systemically delivered oncolytic virus therapies.

TOVX | US

Overview

Corporate Details

ISIN(s):
US87164U5083 (+1 more)
LEI:
Country:
United States of America
Address:
9605 MEDICAL CENTER DRIVE, 20850 ROCKVILLE

Description

Theriva Biologics, Inc. is a clinical-stage immuno-oncology company developing a new class of oncolytic virus therapeutics. The company's platform is engineered for systemic delivery to overcome the protective barrier surrounding solid tumors. These developmental therapies are designed to selectively replicate within and kill tumor cells, with the potential to enhance current standard-of-care treatments. Theriva's lead candidates are being advanced to address a range of difficult-to-treat cancers and diseases in areas of high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-05 09:10
FORM 8-K
English 106.4 KB
2024-11-20 17:42
FORM S-8
English 45.2 KB
2024-11-12 09:18
10-Q
English 1.8 MB
2024-11-12 09:10
FORM 8-K
English 150.7 KB
2024-11-01 17:05
FORM 8-K
English 1.2 MB
2024-10-16 10:10
FORM 8-K
English 106.2 KB
2024-10-03 18:12
SCHEDULE 13G
English 17.6 KB
2024-10-03 10:10
FORM 8-K
English 121.8 KB
2024-10-02 12:53
SC 13G
English 21.1 KB
2024-09-30 22:43
ARS
English 1.2 MB
2024-09-30 19:13
DEF 14A
English 2.3 MB
2024-09-27 21:56
FORM 8-K
English 420.9 KB
2024-09-27 17:20
424B5
English 212.0 KB
2024-09-26 18:10
424B5
English 140.1 KB
2024-09-26 02:15 English 5.3 KB

Automate Your Workflow. Get a real-time feed of all Theriva Biologics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Theriva Biologics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Theriva Biologics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.